A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
Clinical trial NCT05736107 · COMPLETED
Trial details
- NCT number
- NCT05736107
- Sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-30
- Primary completion
- 2024-05-20
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.